Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease

Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to sys...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2019-08, Vol.5 (8), p.eaaw7756-eaaw7756
Hauptverfasser: Goel, Gautam, Tye-Din, Jason A, Qiao, Shuo-Wang, Russell, Amy K, Mayassi, Toufic, Ciszewski, Cezary, Sarna, Vikas K, Wang, Suyue, Goldstein, Kaela E, Dzuris, John L, Williams, Leslie J, Xavier, Ramnik J, Lundin, Knut E A, Jabri, Bana, Sollid, Ludvig M, Anderson, Robert P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page eaaw7756
container_issue 8
container_start_page eaaw7756
container_title Science advances
container_volume 5
creator Goel, Gautam
Tye-Din, Jason A
Qiao, Shuo-Wang
Russell, Amy K
Mayassi, Toufic
Ciszewski, Cezary
Sarna, Vikas K
Wang, Suyue
Goldstein, Kaela E
Dzuris, John L
Williams, Leslie J
Xavier, Ramnik J
Lundin, Knut E A
Jabri, Bana
Sollid, Ludvig M
Anderson, Robert P
description Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4 T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.
doi_str_mv 10.1126/sciadv.aaw7756
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6685723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2281846630</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-841046bfa1b336fa8c92ff85b466ff9ccdcb31061bf2bfef7ca81c02ae07a8d63</originalsourceid><addsrcrecordid>eNpVkc1vGyEQxVHVqonSXHtsOPZil49dwJdKlZW0lSLlkihHNMuCQ8KCA9iV__tg2YnSE4N485s3PIS-UjKnlIkfxXgYt3OAf1L24gM6ZVz2M9Z36uO7-gSdl_JICKGdED1dfEYnnHa9JAt6iu6Xu5qefLQ422ChWAxxxCsoNScfqy3VRwi47KZ1TVPB4KrNeBU21UZsHiAEG1cW-3axwYPBoy97zBf0yUEo9vx4nqG7q8vb5Z_Z9c3vv8tf1zPT0a7OVEdJJwYHdOBcOFBmwZxT_dCsOrcwZjQDp0TQwbHBWScNKGoIA0skqFHwM_TzwF1vhsmOxsaaIeh19hPknU7g9f8v0T_oVdpqIVQvGW-AiwPAZL9fVseUQVOieqalpFw1xffjiJyeN-1H9ORL2zZAtGlTNGOKquaXkyadv8JSKdm6NyOU6H1k-hCZPkbWGr69t_8mfw2IvwDD2JY7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2281846630</pqid></control><display><type>article</type><title>Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease</title><source>MEDLINE</source><source>NORA - Norwegian Open Research Archives</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Goel, Gautam ; Tye-Din, Jason A ; Qiao, Shuo-Wang ; Russell, Amy K ; Mayassi, Toufic ; Ciszewski, Cezary ; Sarna, Vikas K ; Wang, Suyue ; Goldstein, Kaela E ; Dzuris, John L ; Williams, Leslie J ; Xavier, Ramnik J ; Lundin, Knut E A ; Jabri, Bana ; Sollid, Ludvig M ; Anderson, Robert P</creator><creatorcontrib>Goel, Gautam ; Tye-Din, Jason A ; Qiao, Shuo-Wang ; Russell, Amy K ; Mayassi, Toufic ; Ciszewski, Cezary ; Sarna, Vikas K ; Wang, Suyue ; Goldstein, Kaela E ; Dzuris, John L ; Williams, Leslie J ; Xavier, Ramnik J ; Lundin, Knut E A ; Jabri, Bana ; Sollid, Ludvig M ; Anderson, Robert P</creatorcontrib><description>Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4 T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.</description><identifier>ISSN: 2375-2548</identifier><identifier>EISSN: 2375-2548</identifier><identifier>DOI: 10.1126/sciadv.aaw7756</identifier><identifier>PMID: 31457091</identifier><language>eng</language><publisher>United States: American Association for the Advancement of Science</publisher><subject>Adult ; Aged ; CD4-Positive T-Lymphocytes - classification ; CD4-Positive T-Lymphocytes - metabolism ; Celiac Disease - immunology ; Celiac Disease - metabolism ; Celiac Disease - pathology ; Cytokines - blood ; Double-Blind Method ; Female ; Genotype ; Glutens - administration &amp; dosage ; Glutens - adverse effects ; HLA Antigens - genetics ; Humans ; Immunology ; Interleukin-10 - blood ; Interleukin-2 - blood ; Interleukin-8 - blood ; Male ; Middle Aged ; Placebo Effect ; SciAdv r-articles ; Vomiting - etiology ; Young Adult</subject><ispartof>Science advances, 2019-08, Vol.5 (8), p.eaaw7756-eaaw7756</ispartof><rights>info:eu-repo/semantics/openAccess</rights><rights>Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). 2019 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-841046bfa1b336fa8c92ff85b466ff9ccdcb31061bf2bfef7ca81c02ae07a8d63</citedby><cites>FETCH-LOGICAL-c414t-841046bfa1b336fa8c92ff85b466ff9ccdcb31061bf2bfef7ca81c02ae07a8d63</cites><orcidid>0000-0002-5458-1352 ; 0000-0003-1713-5545 ; 0000-0001-7427-4424 ; 0000-0001-8860-704X ; 0000-0002-0046-8426 ; 0000-0002-0764-7267 ; 0000-0002-0034-2807 ; 0000-0003-4054-1074 ; 0000-0002-5630-5167 ; 0000-0001-7687-9654 ; 0000-0002-0578-1497 ; 0000-0002-4716-135X ; 0000-0002-4982-986X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685723/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685723/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,26567,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31457091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goel, Gautam</creatorcontrib><creatorcontrib>Tye-Din, Jason A</creatorcontrib><creatorcontrib>Qiao, Shuo-Wang</creatorcontrib><creatorcontrib>Russell, Amy K</creatorcontrib><creatorcontrib>Mayassi, Toufic</creatorcontrib><creatorcontrib>Ciszewski, Cezary</creatorcontrib><creatorcontrib>Sarna, Vikas K</creatorcontrib><creatorcontrib>Wang, Suyue</creatorcontrib><creatorcontrib>Goldstein, Kaela E</creatorcontrib><creatorcontrib>Dzuris, John L</creatorcontrib><creatorcontrib>Williams, Leslie J</creatorcontrib><creatorcontrib>Xavier, Ramnik J</creatorcontrib><creatorcontrib>Lundin, Knut E A</creatorcontrib><creatorcontrib>Jabri, Bana</creatorcontrib><creatorcontrib>Sollid, Ludvig M</creatorcontrib><creatorcontrib>Anderson, Robert P</creatorcontrib><title>Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease</title><title>Science advances</title><addtitle>Sci Adv</addtitle><description>Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4 T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.</description><subject>Adult</subject><subject>Aged</subject><subject>CD4-Positive T-Lymphocytes - classification</subject><subject>CD4-Positive T-Lymphocytes - metabolism</subject><subject>Celiac Disease - immunology</subject><subject>Celiac Disease - metabolism</subject><subject>Celiac Disease - pathology</subject><subject>Cytokines - blood</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Genotype</subject><subject>Glutens - administration &amp; dosage</subject><subject>Glutens - adverse effects</subject><subject>HLA Antigens - genetics</subject><subject>Humans</subject><subject>Immunology</subject><subject>Interleukin-10 - blood</subject><subject>Interleukin-2 - blood</subject><subject>Interleukin-8 - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Placebo Effect</subject><subject>SciAdv r-articles</subject><subject>Vomiting - etiology</subject><subject>Young Adult</subject><issn>2375-2548</issn><issn>2375-2548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>3HK</sourceid><recordid>eNpVkc1vGyEQxVHVqonSXHtsOPZil49dwJdKlZW0lSLlkihHNMuCQ8KCA9iV__tg2YnSE4N485s3PIS-UjKnlIkfxXgYt3OAf1L24gM6ZVz2M9Z36uO7-gSdl_JICKGdED1dfEYnnHa9JAt6iu6Xu5qefLQ422ChWAxxxCsoNScfqy3VRwi47KZ1TVPB4KrNeBU21UZsHiAEG1cW-3axwYPBoy97zBf0yUEo9vx4nqG7q8vb5Z_Z9c3vv8tf1zPT0a7OVEdJJwYHdOBcOFBmwZxT_dCsOrcwZjQDp0TQwbHBWScNKGoIA0skqFHwM_TzwF1vhsmOxsaaIeh19hPknU7g9f8v0T_oVdpqIVQvGW-AiwPAZL9fVseUQVOieqalpFw1xffjiJyeN-1H9ORL2zZAtGlTNGOKquaXkyadv8JSKdm6NyOU6H1k-hCZPkbWGr69t_8mfw2IvwDD2JY7</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Goel, Gautam</creator><creator>Tye-Din, Jason A</creator><creator>Qiao, Shuo-Wang</creator><creator>Russell, Amy K</creator><creator>Mayassi, Toufic</creator><creator>Ciszewski, Cezary</creator><creator>Sarna, Vikas K</creator><creator>Wang, Suyue</creator><creator>Goldstein, Kaela E</creator><creator>Dzuris, John L</creator><creator>Williams, Leslie J</creator><creator>Xavier, Ramnik J</creator><creator>Lundin, Knut E A</creator><creator>Jabri, Bana</creator><creator>Sollid, Ludvig M</creator><creator>Anderson, Robert P</creator><general>American Association for the Advancement of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>3HK</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5458-1352</orcidid><orcidid>https://orcid.org/0000-0003-1713-5545</orcidid><orcidid>https://orcid.org/0000-0001-7427-4424</orcidid><orcidid>https://orcid.org/0000-0001-8860-704X</orcidid><orcidid>https://orcid.org/0000-0002-0046-8426</orcidid><orcidid>https://orcid.org/0000-0002-0764-7267</orcidid><orcidid>https://orcid.org/0000-0002-0034-2807</orcidid><orcidid>https://orcid.org/0000-0003-4054-1074</orcidid><orcidid>https://orcid.org/0000-0002-5630-5167</orcidid><orcidid>https://orcid.org/0000-0001-7687-9654</orcidid><orcidid>https://orcid.org/0000-0002-0578-1497</orcidid><orcidid>https://orcid.org/0000-0002-4716-135X</orcidid><orcidid>https://orcid.org/0000-0002-4982-986X</orcidid></search><sort><creationdate>20190801</creationdate><title>Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease</title><author>Goel, Gautam ; Tye-Din, Jason A ; Qiao, Shuo-Wang ; Russell, Amy K ; Mayassi, Toufic ; Ciszewski, Cezary ; Sarna, Vikas K ; Wang, Suyue ; Goldstein, Kaela E ; Dzuris, John L ; Williams, Leslie J ; Xavier, Ramnik J ; Lundin, Knut E A ; Jabri, Bana ; Sollid, Ludvig M ; Anderson, Robert P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-841046bfa1b336fa8c92ff85b466ff9ccdcb31061bf2bfef7ca81c02ae07a8d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>CD4-Positive T-Lymphocytes - classification</topic><topic>CD4-Positive T-Lymphocytes - metabolism</topic><topic>Celiac Disease - immunology</topic><topic>Celiac Disease - metabolism</topic><topic>Celiac Disease - pathology</topic><topic>Cytokines - blood</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Genotype</topic><topic>Glutens - administration &amp; dosage</topic><topic>Glutens - adverse effects</topic><topic>HLA Antigens - genetics</topic><topic>Humans</topic><topic>Immunology</topic><topic>Interleukin-10 - blood</topic><topic>Interleukin-2 - blood</topic><topic>Interleukin-8 - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Placebo Effect</topic><topic>SciAdv r-articles</topic><topic>Vomiting - etiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goel, Gautam</creatorcontrib><creatorcontrib>Tye-Din, Jason A</creatorcontrib><creatorcontrib>Qiao, Shuo-Wang</creatorcontrib><creatorcontrib>Russell, Amy K</creatorcontrib><creatorcontrib>Mayassi, Toufic</creatorcontrib><creatorcontrib>Ciszewski, Cezary</creatorcontrib><creatorcontrib>Sarna, Vikas K</creatorcontrib><creatorcontrib>Wang, Suyue</creatorcontrib><creatorcontrib>Goldstein, Kaela E</creatorcontrib><creatorcontrib>Dzuris, John L</creatorcontrib><creatorcontrib>Williams, Leslie J</creatorcontrib><creatorcontrib>Xavier, Ramnik J</creatorcontrib><creatorcontrib>Lundin, Knut E A</creatorcontrib><creatorcontrib>Jabri, Bana</creatorcontrib><creatorcontrib>Sollid, Ludvig M</creatorcontrib><creatorcontrib>Anderson, Robert P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>NORA - Norwegian Open Research Archives</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goel, Gautam</au><au>Tye-Din, Jason A</au><au>Qiao, Shuo-Wang</au><au>Russell, Amy K</au><au>Mayassi, Toufic</au><au>Ciszewski, Cezary</au><au>Sarna, Vikas K</au><au>Wang, Suyue</au><au>Goldstein, Kaela E</au><au>Dzuris, John L</au><au>Williams, Leslie J</au><au>Xavier, Ramnik J</au><au>Lundin, Knut E A</au><au>Jabri, Bana</au><au>Sollid, Ludvig M</au><au>Anderson, Robert P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease</atitle><jtitle>Science advances</jtitle><addtitle>Sci Adv</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>5</volume><issue>8</issue><spage>eaaw7756</spage><epage>eaaw7756</epage><pages>eaaw7756-eaaw7756</pages><issn>2375-2548</issn><eissn>2375-2548</eissn><abstract>Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4 T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.</abstract><cop>United States</cop><pub>American Association for the Advancement of Science</pub><pmid>31457091</pmid><doi>10.1126/sciadv.aaw7756</doi><orcidid>https://orcid.org/0000-0002-5458-1352</orcidid><orcidid>https://orcid.org/0000-0003-1713-5545</orcidid><orcidid>https://orcid.org/0000-0001-7427-4424</orcidid><orcidid>https://orcid.org/0000-0001-8860-704X</orcidid><orcidid>https://orcid.org/0000-0002-0046-8426</orcidid><orcidid>https://orcid.org/0000-0002-0764-7267</orcidid><orcidid>https://orcid.org/0000-0002-0034-2807</orcidid><orcidid>https://orcid.org/0000-0003-4054-1074</orcidid><orcidid>https://orcid.org/0000-0002-5630-5167</orcidid><orcidid>https://orcid.org/0000-0001-7687-9654</orcidid><orcidid>https://orcid.org/0000-0002-0578-1497</orcidid><orcidid>https://orcid.org/0000-0002-4716-135X</orcidid><orcidid>https://orcid.org/0000-0002-4982-986X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2375-2548
ispartof Science advances, 2019-08, Vol.5 (8), p.eaaw7756-eaaw7756
issn 2375-2548
2375-2548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6685723
source MEDLINE; NORA - Norwegian Open Research Archives; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adult
Aged
CD4-Positive T-Lymphocytes - classification
CD4-Positive T-Lymphocytes - metabolism
Celiac Disease - immunology
Celiac Disease - metabolism
Celiac Disease - pathology
Cytokines - blood
Double-Blind Method
Female
Genotype
Glutens - administration & dosage
Glutens - adverse effects
HLA Antigens - genetics
Humans
Immunology
Interleukin-10 - blood
Interleukin-2 - blood
Interleukin-8 - blood
Male
Middle Aged
Placebo Effect
SciAdv r-articles
Vomiting - etiology
Young Adult
title Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A53%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytokine%20release%20and%20gastrointestinal%20symptoms%20after%20gluten%20challenge%20in%20celiac%20disease&rft.jtitle=Science%20advances&rft.au=Goel,%20Gautam&rft.date=2019-08-01&rft.volume=5&rft.issue=8&rft.spage=eaaw7756&rft.epage=eaaw7756&rft.pages=eaaw7756-eaaw7756&rft.issn=2375-2548&rft.eissn=2375-2548&rft_id=info:doi/10.1126/sciadv.aaw7756&rft_dat=%3Cproquest_pubme%3E2281846630%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2281846630&rft_id=info:pmid/31457091&rfr_iscdi=true